This 2025 consensus statement provides visual guidance in graphic algorithms to assist healthcare professionals and adults with obesity and adiposity-based chronic disease (ABCD) in shared decision-making. The algorithm updates the 2016 AACE algorithm, aligning it with related clinical guidance. Surgical and procedural therapies for obesity treatment, as well as care for pediatric-aged patients, are outside the scope of this algorithm. The algorithm includes eleven sections focusing on person-centered and complication-centric management of obesity/ABCD. It addresses screening and diagnosis, encompassing anthropometric and clinical components for diagnosis. An individualized treatment plan, therapeutic goals, and follow-up are included, alongside considerations for response to therapy and weight-loss targets. Behavioral/lifestyle therapy for individuals with obesity/ABCD is also addressed. The algorithm outlines hierarchies of preferred medications for complication-centric care, lower-cost pharmacologic step therapy, and individualization of medication therapy. It references medications approved by the U.S. Food and Drug Administration. The algorithm underscores that ABCD is a complex, chronic disease requiring long-term treatment and care. Emphasis is placed on optimizing health rather than solely weight reduction, and achieving clinical goals beyond a singular focus on body mass index. Individualized interventions, tailored to disease severity or stage, are recommended. Equality of care and reducing weight bias and stigma through a biopsychosocial chronic care model are critical components of this clinical guidance statement.